CQCQ logo

MakingORG, Inc. (CQCQ) Análisis de Acciones

Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

CQCQ representa a MakingORG, Inc., una empresa del sector Healthcare con un precio de $ (capitalización de mercado 0). La acción obtiene una puntuación de 61/100, una calificación moderada basada en 9 KPI cuantitativos.

Ultimo analisis: 16 mar 2026
Puntuación de IA de 61/100

MakingORG, Inc. (CQCQ) Resumen de Asistencia Médica y Tuberías

CEOJuanzi Cui
Empleados2
Sede CentralWalnut, US
Año de la oferta pública inicial (OPI)2014

MakingORG, Inc. (CQCQ) is a micro-cap healthcare company specializing in the distribution of Acer truncatum bunge seed oil to manufacturers in China. Operating with a small team, the company navigates the OTC market while focusing on a niche segment within the broader health products industry, with a negative P/E ratio.

Procedencia de los datos | Datos financieros Análisis cuantitativo NASDAQ Análisis: 16 mar 2026

Tesis de Inversión

Investing in MakingORG, Inc. (CQCQ) presents a high-risk, high-reward scenario. The company's focus on Acer truncatum bunge seed oil caters to a specific niche within the health products market in China. The potential for growth hinges on expanding its customer base and increasing sales volume. However, the company's negative P/E ratio of -322.38 and negative profit margin of -58.2% raise concerns about its financial stability. Key catalysts include potential partnerships with larger health product manufacturers and successful expansion into new geographic regions within China. The company's small size and OTC listing introduce additional risks related to liquidity and regulatory compliance. Investors should carefully consider the company's financial health and market position before investing, as well as the volatility associated with OTC stocks, given its high beta of 4.38.

Basado en las finanzas de FMP y el análisis cuantitativo

Puntos clave

  • Market capitalization of $0.03 billion, classifying it as a micro-cap stock.
  • Negative P/E ratio of -322.38, indicating the company is not currently profitable.
  • Negative profit margin of -58.2%, reflecting significant challenges in cost management and revenue generation.
  • Gross margin of 40.3%, suggesting potential in the core business if operational efficiencies improve.
  • Beta of 4.38, indicating high volatility relative to the market.

Competidores y Pares

Fortalezas

  • Niche market focus on Acer truncatum bunge seed oil.
  • Established presence in the Chinese market.
  • Potential for growth in the expanding health products industry.
  • Gross margin of 40.3% indicates potential profitability.

Debilidades

  • Small company size with limited resources.
  • High dependence on a single product and market.
  • Negative P/E ratio and profit margin raise financial concerns.
  • OTC listing introduces liquidity and regulatory risks.

Catalizadores

  • Upcoming: Potential partnerships with larger health product manufacturers could increase sales volume.
  • Upcoming: Expansion into new geographic regions within China could broaden market reach.
  • Ongoing: Increasing demand for natural health products in China supports growth potential.
  • Ongoing: Research and development efforts may lead to new product applications.
  • Ongoing: Strategic alliances could provide stable revenue streams.

Riesgos

  • Potential: Intense competition from established companies in the health products industry.
  • Potential: Changes in consumer preferences could reduce demand for Acer truncatum bunge seed oil.
  • Potential: Regulatory changes and compliance requirements could increase operating costs.
  • Ongoing: Limited financial resources may hinder growth initiatives.
  • Ongoing: OTC listing introduces liquidity and regulatory risks.

Oportunidades de crecimiento

  • Expansion into New Product Lines: MakingORG can leverage its existing distribution network to offer other raw materials or health-related products derived from Acer truncatum bunge, such as extracts or finished goods. The market for natural health products is expanding, with a projected growth rate of 6-8% annually. Introducing new products could diversify revenue streams and reduce reliance on a single commodity. Timeline: 1-2 years.
  • Geographic Expansion within China: Currently, MakingORG operates primarily within specific regions of China. Expanding its distribution network to other provinces and cities could significantly increase its market reach. The Chinese health product market is vast and diverse, offering ample opportunities for growth in underserved areas. This expansion could be achieved through strategic partnerships or direct investment in new distribution centers. Timeline: 2-3 years.
  • Strategic Partnerships with Manufacturers: Forming strategic alliances with larger health product manufacturers could provide MakingORG with a stable and predictable revenue stream. These partnerships could involve exclusive supply agreements or joint product development initiatives. Collaborating with established brands would also enhance MakingORG's credibility and market visibility. Timeline: 1 year.
  • Online Sales Channels: Establishing an online presence through e-commerce platforms could enable MakingORG to reach a broader customer base and reduce reliance on traditional distribution channels. Online sales of health products are growing rapidly in China, driven by increasing internet penetration and consumer preference for online shopping. This initiative would require investment in digital marketing and logistics infrastructure. Timeline: 1 year.
  • Research and Development: Investing in research and development to explore new applications of Acer truncatum bunge seed oil could create new market opportunities and differentiate MakingORG from its competitors. This could involve collaborating with research institutions or universities to conduct clinical trials and develop innovative health products. Successful R&D efforts could lead to patentable products and a competitive edge. Timeline: 3-5 years.

Oportunidades

  • Expansion into new product lines and geographic regions.
  • Strategic partnerships with larger manufacturers.
  • Increased online sales through e-commerce platforms.
  • Research and development of new applications for Acer truncatum bunge seed oil.

Amenazas

  • Competition from larger and more established companies.
  • Changes in consumer preferences and demand for specific ingredients.
  • Regulatory changes and compliance requirements.
  • Economic fluctuations in the Chinese market.

Ventajas competitivas

  • Specialized Focus: Niche expertise in Acer truncatum bunge seed oil.
  • Established Relationships: Existing relationships with suppliers and manufacturers in China.
  • First-Mover Advantage: Early entrant in the Acer truncatum bunge seed oil market.

Acerca de CQCQ

MakingORG, Inc., formerly known as Drimex Inc., was established in 2012 and is headquartered in Walnut, California. The company's primary business involves the purchase and sale of Acer truncatum bunge seed oil, which it supplies to third-party manufacturers in the People's Republic of China. These manufacturers utilize the oil in the production of various health-related products. The company rebranded in August 2014 to reflect its focus on organic and natural products, specifically those derived from the Acer truncatum bunge tree. MakingORG operates with a very small team, indicating a lean operational structure. Its business is concentrated on a single product line and geographic market, making it susceptible to regional economic conditions and changes in consumer preferences within China. The company's financial performance, as indicated by its negative P/E ratio of -322.38 and a negative profit margin of -58.2%, suggests ongoing challenges in achieving profitability. MakingORG's reliance on a single product and market requires it to maintain strong relationships with its suppliers and customers to ensure business continuity.

Qué hacen

  • Purchases Acer truncatum bunge seed oil.
  • Sells Acer truncatum bunge seed oil to third parties.
  • Supplies raw materials for health product manufacturers.
  • Operates primarily in the People's Republic of China.
  • Focuses on a niche market within the broader health products industry.
  • Distributes Acer truncatum bunge seed oil for use in health-related products.

Modelo de Negocio

  • Procures Acer truncatum bunge seed oil from suppliers.
  • Sells the oil to manufacturers of health products.
  • Generates revenue through the markup on the oil sales.
  • Operates on a business-to-business (B2B) model.

Contexto de la Industria

MakingORG, Inc. operates within the medical distribution industry, specifically focusing on supplying raw materials for health products. The industry is characterized by stringent regulations, evolving consumer preferences, and intense competition. Companies like CHBRF, GENH, HPST, IBXNF, and IGXT represent the competitive landscape. The market for health products in China is growing, driven by increasing health awareness and disposable incomes. However, MakingORG's niche focus on Acer truncatum bunge seed oil makes it vulnerable to shifts in demand for specific ingredients and the emergence of alternative products.

Clientes Clave

  • Health product manufacturers in China.
  • Companies that produce health supplements.
  • Businesses using Acer truncatum bunge seed oil as an ingredient.
Confianza de la IA: 69% Actualizado: 16 mar 2026

Finanzas

Gráfico e información

Precio de la acción de MakingORG, Inc. (CQCQ): Price data unavailable

Últimas noticias

No hay noticias recientes disponibles para CQCQ.

Consenso de analistas

Calificación de Consenso

Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para CQCQ.

Objetivos de Precios

Análisis del precio objetivo de Wall Street para CQCQ.

MoonshotScore

61/100

¿Qué significa esta puntuación?

El MoonshotScore califica el potencial de crecimiento de CQCQ en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.

Liderazgo: Juanzi Cui

CEO

Juanzi Cui serves as the CEO of MakingORG, Inc. With a small team of two employees, Cui is responsible for overseeing all aspects of the company's operations, from sourcing Acer truncatum bunge seed oil to managing sales and distribution in the Chinese market. Information regarding Cui's prior experience and educational background is not available.

Historial: Due to the limited information available, it is difficult to assess Juanzi Cui's track record. The company's financial performance, as indicated by its negative P/E ratio and profit margin, suggests ongoing challenges. However, Cui's leadership in navigating the OTC market and maintaining a gross margin of 40.3% demonstrates some level of operational effectiveness.

Información del mercado OTC de CQCQ

The OTC Other tier represents the lowest tier of the OTC market, encompassing stocks that are not eligible for OTCQX or OTCQB. These securities often lack current information and may be difficult to value due to limited financial disclosure. Companies in this tier may not meet minimum financial standards or have chosen not to comply with reporting requirements, increasing investment risk compared to stocks listed on major exchanges like the NYSE or NASDAQ.

  • Nivel OTC: OTC Other
  • Estado de divulgación: Unknown
Liquidez: Liquidity for CQCQ is likely very limited, given its OTC Other listing and micro-cap status. This can result in wide bid-ask spreads and difficulty in buying or selling shares without significantly impacting the price. Investors should be prepared for potential delays and higher transaction costs when trading CQCQ.
Factores de riesgo OTC:
  • Limited Liquidity: Difficulty in buying or selling shares due to low trading volume.
  • Lack of Transparency: Unknown disclosure status raises concerns about financial reporting.
  • Regulatory Risks: OTC Other stocks are subject to less regulatory oversight.
  • Valuation Challenges: Limited information makes it difficult to assess the company's true value.
  • Potential for Fraud: Higher risk of fraudulent activity compared to listed companies.
Lista de verificación de diligencia debida:
  • Verify the company's legal status and registration.
  • Attempt to obtain and review any available financial statements.
  • Assess the company's management team and their experience.
  • Understand the company's business model and competitive landscape.
  • Evaluate the potential risks and rewards of investing in CQCQ.
  • Consult with a financial advisor before making any investment decisions.
  • Check for any history of regulatory violations or legal issues.
Señales de legitimidad:
  • Company has been in operation since 2012.
  • Focus on a specific niche market (Acer truncatum bunge seed oil).
  • Gross margin of 40.3% suggests a viable business model.
  • Company headquarters are located in Walnut, California.

Preguntas Comunes Sobre CQCQ

¿Cuáles son los factores clave para evaluar CQCQ?

MakingORG, Inc. (CQCQ) actualmente tiene una puntuación IA de 61/100, indicando puntuación moderada. Fortaleza clave: Niche market focus on Acer truncatum bunge seed oil.. Riesgo principal a monitorear: Potential: Intense competition from established companies in the health products industry.. Esto no es asesoramiento financiero.

¿Qué es el MoonshotScore de CQCQ?

CQCQ actualmente puntúa 61/100 (Grado B) en el MoonshotScore, lo que sugiere calificación moderada. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.

¿Con qué frecuencia se actualizan los datos de CQCQ?

Los precios de CQCQ se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.

¿Qué dicen los analistas sobre CQCQ?

La cobertura de analistas para CQCQ incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.

¿Cuáles son los riesgos de invertir en CQCQ?

Las categorías de riesgo para CQCQ incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Intense competition from established companies in the health products industry.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.

¿Cuál es la relación P/E de CQCQ?

La relación P/E para CQCQ compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.

¿Está CQCQ sobrevalorada o infravalorada?

Determinar si MakingORG, Inc. (CQCQ) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.

¿Cuál es el rendimiento por dividendo de CQCQ?

MakingORG, Inc. (CQCQ) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.

Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.

Recursos Oficiales

Análisis actualizado el Puntuación de IA actualizada diariamente
Fuentes de Datos y Metodología
Datos de mercado proporcionados por Financial Modeling Prep y Yahoo Finance. Análisis de IA por algoritmos propietarios de Stock Expert AI. Indicadores técnicos mediante cálculos estándar de la industria. Última actualización: .

Datos proporcionados solo con fines informativos.

Notas de análisis
  • Limited information available for this company due to its OTC listing and micro-cap status.
  • Financial data is based on available information and may not be comprehensive.
  • AI analysis is pending and may provide additional insights in the future.
Fuentes de datos

Popular Stocks